The label says yes. The dose says no.
Walk into any pharmacy and pick up a bottle of ashwagandha. The label will tell you it supports stress, sleep, and recovery. What the label will not tell you is that the studies behind those claims used 600 mg of standardized KSM-66 extract per day, and the bottle in your hand contains 125 mg of a non-standardized root powder. The molecule is technically present. The clinical effect is not.
This is the core problem with the modern supplement market. Ingredients are chosen for marketing weight, not for the dose that the underlying research validated.
Why dosing gets cut
Active ingredients at clinical strength cost real money. A 600 mg KSM-66 dose, a 275 mg magnesium glycinate dose, a 300 mg NMN dose, these add up fast at scale. Brands face a choice. Either price the product where the dose can survive, or cut the dose to hit a competitive shelf price.
Most cut the dose. The label still lists the ingredient. The marketing still references the studies. The customer assumes the product delivers what the research described. The product does not.
How to read past it
Three checks separate clinical-dose products from underdosed lookalikes.
One. Check elemental weight, not compound weight. A 500 mg magnesium oxide capsule contains roughly 300 mg of elemental magnesium. A 500 mg magnesium glycinate capsule contains roughly 65 mg. The compound weight on the label is not the dose your body sees.
Two. Check the trial.
Look up the actual study the brand cites. Compare the dose used in the trial to the dose in the bottle. If the bottle is 80 percent of the trial dose or less, the brand is selling the marketing without the mechanism.
Three. Check standardization. Plant extracts vary wildly in active-compound concentration. A standardized extract guarantees a fixed percentage of the active. Non-standardized powders do not. KSM-66, for example, is standardized to 5 percent withanolides. Generic ashwagandha powder may contain a tenth of that, or less.
What we do
AE·ORA formulates each product at the dose the peer-reviewed literature validated. Magnesium glycinate at 275 mg elemental. KSM-66 at 600 mg standardized. NMN at 500 mg. Methylated B-complex with active forms, not cyanocobalamin shells.
The price reflects the formulation. The formulation reflects the research.
